Design, synthesis and biological evaluation of novel CDK8/BRD4 dual inhibitors
{{output}}
CDK8 is recognized as an important therapeutic target in colorectal cancer. Recently, a study has demonstrated that inhibition of CDK8 alone can activate a compensatory BRD4 signaling pathway, which may account for the modest in vivo efficacy of CDK8 small-mol... ...
